Working… Menu

Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00394992
Recruitment Status : Terminated (Data from the C08 study and Avant study)
First Posted : November 2, 2006
Last Update Posted : February 4, 2014
Roche Pharma AG
Information provided by (Responsible Party):
Dutch Colorectal Cancer Group